Home › Funds › DV EQUITIES, LLC › CTMX
DV EQUITIES, LLC position in CTMX
CYTOMX THERAPEUTICS INC. · Health Care
DV EQUITIES, LLC reported holding 714,000 shares of CTMX (CYTOMX THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.38% of its reported portfolio and ranking #34 among its reported holdings. DV EQUITIES, LLC has disclosed CTMX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How DV EQUITIES, LLC's CTMX position evolved
DV EQUITIES, LLC first disclosed a stake in CTMX in Q2 2026 at 714,000 shares (US$2.7M). Across 2 filings, DV EQUITIES, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 714,000 shares valued at US$1.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 714.00K | $2.68M | New |
| Q3 2026 | 714.00K | $1.94M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CTMX and 13F data
CTMX (CYTOMX THERAPEUTICS INC.) is a Health Care company. 33 other funds we track also report a position in CTMX — the largest reported positions include Kynam Capital Management, LP (US$57.5M), PERCEPTIVE ADVISORS LLC (US$25.2M), Elmind Capital, LP (US$12.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CTMX
- Kynam Capital Management, LP 21.14M sh · $57.50M · Q3 2026
- PERCEPTIVE ADVISORS LLC 9.27M sh · $25.21M · Q3 2026
- Elmind Capital, LP 4.55M sh · $12.38M · Q3 2026
- Nextech Invest Ltd. 4.45M sh · $12.10M · Q3 2026
- Eversept Partners, LP 3.54M sh · $9.64M · Q3 2026
- Seven Fleet Capital Management LP 1.09M sh · $2.95M · Q3 2026
More on DV EQUITIES, LLC
FAQ
How long has DV EQUITIES, LLC held CTMX?
DV EQUITIES, LLC has disclosed CTMX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is DV EQUITIES, LLC's current position in CTMX?
As of Q3 2026, DV EQUITIES, LLC holds 714.00K shares of CTMX (CYTOMX THERAPEUTICS INC.), valued at $1.94M, representing 0.38% of its reported portfolio and ranking #34.
Has DV EQUITIES, LLC been buying or selling CTMX?
In the latest 13F filing (Q3 2026), DV EQUITIES, LLC held unchanged its position in CTMX.
Which other funds hold CTMX?
Other major institutional holders of CTMX include Kynam Capital Management, LP, PERCEPTIVE ADVISORS LLC, Elmind Capital, LP, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.